Regeneron price target lowered to $800 from $990 at HSBC
HSBC lowered the firm's price target on Regeneron to $800 from $990 and keeps a Buy rating on the shares. In a sector note on Healthcare, HSBC adjusted target prices on the prospects of the sector's relative outperformance potential for the second half of the year, noting that the Therapeutics space offering "attractiv